(2-Carbamimidoyl-1-benzothiophen-6-yl) thiophene-2-carboxylate, also known as CBTC, is a synthetic compound that has gained attention in recent years due to its potential therapeutic and environmental applications. CBTC belongs to the class of thiophene derivatives, which have been extensively studied for their biological and pharmacological properties.
(2-Carbamimidoyl-1-benzothiophen-6-yl) thiophene-2-carboxylate can be synthesized using various methods, including the reaction of 2-thiophenecarboxylic acid with thiourea in the presence of a catalyst, or the reaction of 2-thiophenecarboxylic acid with cyanamide and ammonium carbonate. The efficiency and yield of each method depend on the reaction conditions, such as temperature, pressure, and reaction time. The environmental and safety considerations of (2-Carbamimidoyl-1-benzothiophen-6-yl) thiophene-2-carboxylate synthesis include the use of hazardous chemicals and the generation of waste products. Therefore, it is essential to follow proper safety protocols and dispose of the waste products appropriately.
Chemical Structure and Biological Activity
The chemical structure of (2-Carbamimidoyl-1-benzothiophen-6-yl) thiophene-2-carboxylate consists of a thiophene ring attached to a benzothiophene ring, with a carboxylate and carbamimidoyl group attached to the thiophene ring. (2-Carbamimidoyl-1-benzothiophen-6-yl) thiophene-2-carboxylate has been shown to exhibit potent antitumor activity by inhibiting the growth of cancer cells. The mechanism of action of (2-Carbamimidoyl-1-benzothiophen-6-yl) thiophene-2-carboxylate involves the inhibition of tubulin polymerization, which is essential for cell division. (2-Carbamimidoyl-1-benzothiophen-6-yl) thiophene-2-carboxylate has also been shown to have antibacterial and antifungal activity by disrupting the cell membrane of microorganisms.
Biological Effects
(2-Carbamimidoyl-1-benzothiophen-6-yl) thiophene-2-carboxylate has been shown to have potential therapeutic effects on various diseases, including cancer, bacterial and fungal infections, and inflammation. However, (2-Carbamimidoyl-1-benzothiophen-6-yl) thiophene-2-carboxylate may also have toxic effects on normal cells and tissues, which need to be further studied. (2-Carbamimidoyl-1-benzothiophen-6-yl) thiophene-2-carboxylate has been shown to affect cell function and signal transduction by inhibiting the activity of enzymes and receptors involved in cell signaling pathways.
Applications
In medical research, (2-Carbamimidoyl-1-benzothiophen-6-yl) thiophene-2-carboxylate has been studied for its potential role in drug development, particularly in the treatment of cancer and infectious diseases. Clinical trials have shown promising results in the use of (2-Carbamimidoyl-1-benzothiophen-6-yl) thiophene-2-carboxylate as a chemotherapeutic agent. However, further studies are needed to determine the safety and efficacy of (2-Carbamimidoyl-1-benzothiophen-6-yl) thiophene-2-carboxylate in humans. In environmental research, (2-Carbamimidoyl-1-benzothiophen-6-yl) thiophene-2-carboxylate has been studied for its effects on ecosystems and its potential role in pollution management. (2-Carbamimidoyl-1-benzothiophen-6-yl) thiophene-2-carboxylate has been shown to have low toxicity to aquatic organisms, making it a potential candidate for the treatment of contaminated water. In industrial research, (2-Carbamimidoyl-1-benzothiophen-6-yl) thiophene-2-carboxylate has been used in manufacturing processes to improve product quality and efficiency. Health and safety considerations need to be taken into account when using (2-Carbamimidoyl-1-benzothiophen-6-yl) thiophene-2-carboxylate in industrial applications.
Future Perspectives and Challenges
The current limitations in the use and study of (2-Carbamimidoyl-1-benzothiophen-6-yl) thiophene-2-carboxylate include the lack of understanding of its toxicity and potential side effects. Further studies are needed to determine the safety and efficacy of (2-Carbamimidoyl-1-benzothiophen-6-yl) thiophene-2-carboxylate in humans and the environment. Possible solutions and improvements include the development of more efficient and environmentally friendly methods of (2-Carbamimidoyl-1-benzothiophen-6-yl) thiophene-2-carboxylate synthesis and the identification of new biological targets for (2-Carbamimidoyl-1-benzothiophen-6-yl) thiophene-2-carboxylate. Future trends and prospects in the application of (2-Carbamimidoyl-1-benzothiophen-6-yl) thiophene-2-carboxylate in scientific research include the development of new drugs and therapies for various diseases and the use of (2-Carbamimidoyl-1-benzothiophen-6-yl) thiophene-2-carboxylate in environmental remediation. Conclusion: In conclusion, (2-Carbamimidoyl-1-benzothiophen-6-yl) thiophene-2-carboxylate is a synthetic compound with potential therapeutic and environmental applications. The methods of synthesis, chemical structure, biological activity, and potential applications of (2-Carbamimidoyl-1-benzothiophen-6-yl) thiophene-2-carboxylate have been discussed in this paper. Further studies are needed to determine the safety and efficacy of (2-Carbamimidoyl-1-benzothiophen-6-yl) thiophene-2-carboxylate in humans and the environment. The development of more efficient and environmentally friendly methods of (2-Carbamimidoyl-1-benzothiophen-6-yl) thiophene-2-carboxylate synthesis and the identification of new biological targets for (2-Carbamimidoyl-1-benzothiophen-6-yl) thiophene-2-carboxylate are essential for the future application of (2-Carbamimidoyl-1-benzothiophen-6-yl) thiophene-2-carboxylate in scientific research.
Product FAQ
Q1: How Can I Obtain a Quote for a Product I'm Interested In?
To receive a quotation, send us an inquiry about the desired product.
The quote will cover pack size options, pricing, and availability details.
If applicable, estimated lead times for custom synthesis or sourcing will be provided.
Quotations are valid for 30 days, unless specified otherwise.
Q2: What Are the Payment Terms for Ordering Products?
New customers generally require full prepayment.
NET 30 payment terms can be arranged for customers with established credit.
Contact our customer service to set up a credit account for NET 30 terms.
We accept purchase orders (POs) from universities, research institutions, and government agencies.
Q3: Which Payment Methods Are Accepted?
Preferred methods include bank transfers (ACH/wire) and credit cards.
Request a proforma invoice for bank transfer details.
For credit card payments, ask sales representatives for a secure payment link.
Checks aren't accepted as prepayment, but they can be used for post-payment on NET 30 orders.
Q4: How Do I Place and Confirm an Order?
Orders are confirmed upon receiving official order requests.
Provide full prepayment or submit purchase orders for credit account customers.
Send purchase orders to sales@thebiotek.com.
A confirmation email with estimated shipping date follows processing.
Q5: What's the Shipping and Delivery Process Like?
Our standard shipping partner is FedEx (Standard Overnight, 2Day, FedEx International Priority), unless otherwise agreed.
You can use your FedEx account; specify this on the purchase order or inform customer service.
Customers are responsible for customs duties and taxes on international shipments.
Q6: How Can I Get Assistance During the Ordering Process?
Reach out to our customer service representatives at sales@thebiotek.com.
For ongoing order updates or questions, continue using the same email.
Remember, we're here to help! Feel free to contact us for any queries or further assistance.
Quick Inquiry
Note: Kindly utilize formal channels such as professional, corporate, academic emails, etc., for inquiries. The use of personal email for inquiries is not advised.
BCX 1470 methanesulfonate is a small molecule inhibitor that has gained significant attention in the scientific community due to its potential therapeutic applications. It is a potent inhibitor of inosine monophosphate dehydrogenase (IMPDH), an enzyme that plays a crucial role in the de novo synthesis of guanine nucleotides.
Selective mGlu1 antagonist (Ki = 13 nM). Inhibits mGlu1-mediated inositol phosphate production in rat cerebellar granule cells (IC50 = 13 nM). Displays antinociceptive and analgesic effects in vitro; exhibits no significant sedative effect on locomotor activity.
N-[2,6-Bis(1-methylethyl)phenyl]-N'-[4-[(4-nitrophenyl)thio]phenyl]urea, also known as BAY 43-9006 or Sorafenib, is a small molecule drug that has been approved by the US Food and Drug Administration (FDA) for the treatment of advanced renal cell carcinoma and hepatocellular carcinoma. It is a multi-kinase inhibitor that targets several signaling pathways involved in tumor growth and angiogenesis.
Edelfosine is a synthetic alkyl-lysophospholipid that has been extensively studied for its potential therapeutic applications in various diseases, including cancer, parasitic infections, and autoimmune disorders. It was first synthesized in the 1980s and has since been the subject of numerous studies investigating its chemical structure, biological activity, and potential clinical applications.
SD 1008 is a small molecule inhibitor that has been extensively studied for its potential therapeutic applications in various fields of research. It is a potent inhibitor of the JAK2/STAT3 signaling pathway, which plays a crucial role in cell proliferation, differentiation, and survival.
Sulprostone is a synthetic analogue of prostaglandin E2 (PGE2) that has been used in various medical and industrial applications. It is a potent uterine stimulant and has been used in obstetrics and gynecology for the induction of labor, termination of pregnancy, and treatment of postpartum hemorrhage. Sulprostone has also been studied for its potential therapeutic effects in various diseases, including cancer, asthma, and glaucoma.
Selective urotensin-II (UT) receptor antagonist (Ki values are 61, 17, 30, 65 and 56 nM at human, monkey, cat, rat and mouse receptors respectively). Inhibits U-II-induced intracellular Ca2+ mobilization (IC50 = 180 nM) and antagonizes the contractile action of U-II in isolated mammalian arteries and aortae (EC50 = 50 - 189 nM).
Gisadenafil besylate is a phosphodiesterase type 5 (PDE5) inhibitor that is used in the treatment of erectile dysfunction. It is a potent and selective inhibitor of PDE5, which is responsible for the degradation of cyclic guanosine monophosphate (cGMP) in the corpus cavernosum of the penis. Gisadenafil besylate has been shown to be effective in improving erectile function in men with erectile dysfunction, with a favorable safety profile.